Journal
SCIENCE
Volume 372, Issue 6546, Pages 1056-+Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.abe9124
Keywords
-
Categories
Funding
- Australian Research Council (ARC) [DP170103631, DP201102776, CE140100011]
- National Health and Medical Research Council of Australia (NHMRC) [APP1182086, APP1155162]
- NSW Cancer Council [APP1128488]
- Singapore Ministry of Health's National Medical Research Council [CBRG/0097/2015]
- Singapore Ministry of Education [2014-T2-1136]
- ARC Future Fellowship
- NHMRC Senior Research Fellowship
- ARC Laureate Fellowship
Ask authors/readers for more resources
The study found that the T cell receptor recognizes peptide-major histocompatibility complexes with a highly conserved docking polarity, which affects T cell activation and recruitment in vivo. The canonical docking of TCR-pMHCI is essential for optimal T cell signaling.
T cell receptor (TCR) recognition of peptide-major histocompatibility complexes (pMHCs) is characterized by a highly conserved docking polarity. Whether this polarity is driven by recognition or signaling constraints remains unclear. Using reversed-docking TCRb-variable (TRBV) 17(+) TCRs from the naive mouse CD8(+) T cell repertoire that recognizes the H-2D(b)-NP366 epitope, we demonstrate that their inability to support T cell activation and in vivo recruitment is a direct consequence of reversed docking polarity and not TCR-pMHCI binding or clustering characteristics. Canonical TCR-pMHCI docking optimally localizes CD8/Lck to the CD3 complex, which is prevented by reversed TCR-pMHCI polarity. The requirement for canonical docking was circumvented by dissociating Lck from CD8. Thus, the consensus TCR-pMHC docking topology is mandated by T cell signaling constraints.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available